Swedish investment firm EQT has emerged as the sole bidder for OmniActive Health Technologies after the company rejected a competing offer from Temasek and Novo Holdings. OmniActive, backed by TA Associates, has a strong position in nutraceuticals and a notable export footprint in the United States, making the sale a key development for the sector.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
